X-linked myopathy with excessive autophagy: a failure of self-eating

Acta Neuropathologica

Volumn 129, Issue 3, 2015, Pages 383-390

  Dowling, James J ^a   Moore, Steven A ^b   Kalimo, Hannu ^c   Minassian, Berge A ^a  

^a HOSPITAL FOR SICK CHILDREN   (Canada)

^b UNIVERSITY OF IOWA   (United States)

^c UNIVERSITY OF HELSINKI   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

HYDROLASE; PROTEIN; UNCLASSIFIED DRUG; VMA21 PROTEIN; PROTON TRANSPORTING ADENOSINE TRIPHOSPHATE SYNTHASE; VMA21 PROTEIN, HUMAN;

AUTOLYSOSOME; AUTOPHAGY; CELL VACUOLE; CLINICAL FEATURE; CREATINE KINASE BLOOD LEVEL; EATING HABIT; GENE; GENE MUTATION; GENETIC LINKAGE; HUMAN; INTERNALIZATION; MUSCLE BIOPSY; MUSCLE CELL; MYOPATHY; PH; PRIORITY JOURNAL; PROTEIN DEGRADATION; REVIEW; SKELETAL MUSCLE; VMA21 GENE; X CHROMOSOME LINKED DISORDER; X LINKED MYOPATHY WITH EXCESSIVE AUTOPHAGY; GENETICS; LYSOSOME STORAGE DISEASE; MUSCLE DISEASE; PATHOPHYSIOLOGY; PHYSIOLOGY;

AUTOPHAGY; HUMANS; LYSOSOMAL STORAGE DISEASES; MUSCULAR DISEASES; VACUOLAR PROTON-TRANSLOCATING ATPASES;

EID: 84925491282     PISSN: 00016322     EISSN: 14320533     Source Type: Journal    
DOI: 10.1007/s00401-015-1393-4     Document Type: Review

References (42)

1. Chabrol B, Figarella-Branger D, Coquet M et al (2001) X-linked myopathy with excessive autophagy: a clinicopathological study of five new families. Neuromuscul Disord 11:376–388
2. Choi AMK, Ryter SW, Levine B (2013) Autophagy in human health and disease. N Engl J Med 368:1845–1846. doi:10.1056/NEJMc1303158
3. Chow G, Beesley CE, Robson K et al (2006) Case of X-linked myopathy with excessive autophagy. J Child Neurol 21:431–433
4. Crockett CD, Ruggieri A, Gujrati M et al (2014) Late-adult onset of X-linked myopathy with excessive autophagy (XMEA). Muscle Nerve 50(1):138–144. doi:10.1002/mus.24197
5. Damme M, Suntio T, Saftig P, Eskelinen E-L (2014) Autophagy in neuronal cells: general principles and physiological and pathological functions. Acta Neuropathol. doi:10.1007/s00401-014-1361-4
6. De Palma C, Morisi F, Cheli S et al (2012) Autophagy as a new therapeutic target in Duchenne muscular dystrophy. Cell Death Dis 3:e418. doi:10.1038/cddis.2012.159
7. Endo Y, Furuta A, Nishino I (2015) Danon disease: a phenotypic expression of LAMP2-deficiency. Acta Neuropathol [Epub ahead of print]. doi:10.1007/s00401-015-1385-4
8. Grumati P, Coletto L, Sabatelli P et al (2010) Autophagy is defective in collagen VI muscular dystrophies, and its reactivation rescues myofiber degeneration. Nat Med 16:1313–1320. doi:10.1038/nm.2247
9. Hansen TE, Johansen T (2011) Following autophagy step by step. BMC Biol 9:39. doi:10.1186/1741-7007-9-39
10. Holton JL, Beesley C, Jackson M et al (2006) Autophagic vacuolar myopathy in twin girls. Neuropathol Appl Neurobiol 32:253–259. doi:10.1111/j.1365-2990.2006.00691.x
11. Huynh C, Roth D, Ward DM et al (2004) Defective lysosomal exocytosis and plasma membrane repair in Chediak-Higashi/beige cells. Proc Natl Acad Sci 101:16795–16800. doi:10.1073/pnas.0405905101
12. Jääskeläinen SK, Juel VC, Udd B et al (2002) Electrophysiological findings in X-linked myopathy with excessive autophagy. Ann Neurol 51:648–652. doi:10.1002/ana.10173
13. Kalimo H, Savontaus ML, Lang H et al (1988) X-linked myopathy with excessive autophagy: a new hereditary muscle disease. Ann Neurol 23:258–265. doi:10.1002/ana.410230308
14. Katzin LW, Amato AA (2008) Pompe disease: a review of the current diagnosis and treatment recommendations in the era of enzyme replacement therapy. J Clin Neuromuscul Dis 9:421–431. doi:10.1097/CND.0b013e318176dbe4
15. Klionsky DJ, Codogno P (2013) The mechanism and physiological function of macroautophagy. J Innate Immun 5:427–433. doi:10.1159/000351979
16. Kurashige T, Takahashi T, Yamazaki Y et al (2013) Elevated urinary β2 microglobulin in the first identified Japanese family afflicted by X-linked myopathy with excessive autophagy. Neuromuscul Disord 23:911–916. doi:10.1016/j.nmd.2013.06.003
17. Louboutin JP, Villanova M, Ulrich G et al (1996) Elevated levels of complement components C5 and C9 and decreased antitrypsin activity in the serum of patients with X-linked vacuolated myopathy. Muscle Nerve 19:1144–1147. doi:10.1002/(SICI)1097-4598(199609)19:9<1144:AID-MUS10>3.0.CO;2-V
18. Louboutin JP, Villanova M, Lucas-Héron B, Fardeau M (1997) X-linked vacuolated myopathy: membrane attack complex deposition on muscle fiber membranes with calcium accumulation on sarcolemma. Ann Neurol 41:117–120. doi:10.1002/ana.410410121
19. Malicdan MCV, Noguchi S, Nishino I (2007) Autophagy in a mouse model of distal myopathy with rimmed vacuoles or hereditary inclusion body myopathy. Autophagy 3:396–398
20. Malicdan MC, Noguchi S, Nonaka I et al (2008) Lysosomal myopathies: an excessive build-up in autophagosomes is too much to handle. Neuromuscul Disord 18:521–529. doi:10.1016/j.nmd.2008.04.010
21. Masiero E, Agatea L, Mammucari C et al (2009) Autophagy is required to maintain muscle mass. Cell Metab 10:507–515. doi:10.1016/j.cmet.2009.10.008
22. Merlini L, Nishino I, Consortium for Autophagy in Muscular Dystrophies (2014) 201st ENMC International Workshop: autophagy in muscular dystrophies—Translational approach, 1–3 November 2013, Bussum, The Netherlands. Neuromuscul Disord. doi:10.1016/j.nmd.2014.03.009
23. Minassian BA, Aiyar R, Alic S et al (2002) Narrowing in on the causative defect of an intriguing X-linked myopathy with excessive autophagy. Neurology 59:596–601
24. Mindell JA (2012) Lysosomal acidification mechanisms. Annu Rev Physiol 74:69–86. doi:10.1146/annurev-physiol-012110-142317
25. Munteanu I, Ackerley CA, Mnatzakanian GN et al (2005) Electrophysiology extends the phenotypic spectrum of X-linked myopathy with excessive autophagy. Neurology 64:927–928. doi:10.1212/01.WNL.0000152884.11980.53
26. Munteanu I, Ramachandran N, Mnatzakanian GN et al (2008) Fine-mapping the gene for X-linked myopathy with excessive autophagy. Neurology 71:951–953. doi:10.1212/01.wnl.0000325991.01899.35
27. Munteanu I, Ramachandran N, Ruggieri A et al (2015) Congenital autophagic vacuolar myopathy is allelic to X-linked myopathy with excessive autophagy. Neurology (in press)
28. Nemazanyy I, Blaauw B, Paolini C et al (2013) Defects of Vps15 in skeletal muscles lead to autophagic vacuolar myopathy and lysosomal disease. EMBO Mol Med 5:870–890. doi:10.1002/emmm.201202057
29. Nishino I (2006) Autophagic vacuolar myopathy. Semin Pediatr Neurol 13:90–95. doi:10.1016/j.spen.2006.06.004
30. Parzych KR, Klionsky DJ (2014) An overview of autophagy: morphology, mechanism, and regulation. Antioxid Redox Signal 20:460–473. doi:10.1089/ars.2013.5371
31. Platt FM, Boland B, van der Spoel AC (2012) The cell biology of disease: lysosomal storage disorders: the cellular impact of lysosomal dysfunction. J Cell Biol 199:723–734. doi:10.1083/jcb.201208152
32. Ramachandran N, Munteanu I, Wang P et al (2013) VMA21 deficiency prevents vacuolar ATPase assembly and causes autophagic vacuolar myopathy. Acta Neuropathol 125:439–457. doi:10.1007/s00401-012-1073-6
33. Reifler A, Li X, Archambeau AJ et al (2014) Conditional knockout of Pik3c3 causes a murine muscular dystrophy. Am J Pathol. doi:10.1016/j.ajpath.2014.02.012
34. Ruggieri A, Ramachandran N, Wang P et al (2015) Non-coding VMA21 deletions cause X-linked myopathy with excessive autophagy. Neuromusc Dis (in press)
35. Saviranta P, Lindlöf M, Lehesjoki AE et al (1988) Linkage studies in a new X-linked myopathy, suggesting exclusion of DMD locus and tentative assignment to distal Xq. Am J Hum Genet 42:84–88
36. Spampanato C, Feeney E, Li L et al (2013) Transcription factor EB (TFEB) is a new therapeutic target for Pompe disease. EMBO Mol Med 5:691–706. doi:10.1002/emmm.201202176
37. Sugie K, Noguchi S, Kozuka Y et al (2005) Autophagic vacuoles with sarcolemmal features delineate Danon disease and related myopathies. J Neuropathol Exp Neurol 64:513–522
38. Sun-Wada G-H, Wada Y (2013) Vacuolar-type proton pump ATPases: acidification and pathological relationships. Histol Histopathol 28:805–815
39. Villanova M, Louboutin JP, Chateau D et al (1995) X-linked vacuolated myopathy: complement membrane attack complex on surface membrane of injured muscle fibers. Ann Neurol 37:637–645. doi:10.1002/ana.410370514
40. Villard L, Portes des V, Levy N et al (2000) Linkage of X-linked myopathy with excessive autophagy (XMEA) to Xq28. Eur J Hum Genet 8:125–129. doi:10.1038/sj.ejhg.5200432
41. Xie Z, Klionsky DJ (2007) Autophagosome formation: core machinery and adaptations. Nat Cell Biol 9:1102–1109. doi:10.1038/ncb1007-1102
42. Yan C, Tanaka M, Sugie K et al (2005) A new congenital form of X-linked autophagic vacuolar myopathy. Neurology 65:1132–1134. doi:10.1212/01.wnl.0000178979.19887.f5